Recro Appoints Eduardo Uribe as Head of Quality for Recro San Diego
January 19, 2022 07:00 ET
|
Recro Pharma, Inc.
SAN DIEGO and GAINESVILLE, Ga., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
Recro Reports Inducement Grants For New Staff
January 06, 2022 16:05 ET
|
Recro Pharma, Inc.
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Recro to Present at H.C. Wainwright BioConnect 2022 Conference
January 03, 2022 07:00 ET
|
Recro Pharma, Inc.
SAN DIEGO and GAINESVILLE, Ga., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
Recro to Report Financial Results for Third Quarter 2021 on November 9, 2021
November 02, 2021 16:05 ET
|
Recro Pharma, Inc.
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Recro Pharma, Inc.
June 04, 2018 16:12 ET
|
Federman & Sherwood
OKLAHOMA CITY, June 04, 2018 (GLOBE NEWSWIRE) -- Federman & Sherwood announces that on May 31, 2018, a class action lawsuit was filed in the United States District Court for the Eastern District...